BiotechTube
SmartCardia

SmartCardia

Lausanne, Switzerland· Est.
smartcardia.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15.5M

Overview

SmartCardia is a commercial-stage company offering an integrated hardware and software solution for remote cardiac monitoring. Its core product is a reusable, 7-lead ECG patch capable of 7-14 day wear, paired with a cloud-based AI analytics platform called SmartNeuralNet. The platform has received FDA clearance for outpatient cardiac telemetry and CE Mark approval in Europe, positioning it for growth in the remote patient monitoring and telecardiology markets. The company targets hospitals and clinics by aiming to improve diagnostic accuracy and operational efficiency.

Cardiovascular

Technology Platform

SmartCardia 7L Patch (7/14-day wearable for 7-lead ECG, respiration, SpO2, activity) paired with SmartNeuralNet AI cloud platform for automated, full-disclosure arrhythmia detection and remote patient monitoring.

Funding History

3
Total raised:$15.5M
Series B$10M
Series A$4.5M
Seed$1M

Opportunities

The global shift towards remote patient monitoring and value-based care creates a massive opportunity for SmartCardia's integrated platform.
Its ability to serve multiple monitoring service types (Holter, MCT, RPM) from one device allows healthcare providers to streamline operations and capture revenue across the patient care continuum, from diagnosis to chronic disease management.

Risk Factors

Key risks include intense competition from established medical device companies and startups, the challenge of changing clinician behavior and penetrating entrenched healthcare systems, and the ongoing complexity of securing favorable reimbursement from payers in different geographic markets.

Competitive Landscape

SmartCardia competes in the remote cardiac monitoring space against large incumbents like Philips (BioTelemetry) and iRhythm, as well as other wearable patch providers. Its primary competitive advantages are its 7-lead ECG data quality, multi-parameter sensing, full-disclosure AI analysis, and the operational flexibility of its 'Switch 48h' platform that consolidates multiple traditional monitoring services.

More companies in Switzerland →